Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
Go back to Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study| (NYSE: RCUS) | Delayed: 23.80 +0.50 (2.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.30 | 52 Week High | $ | |||
| Open | $23.50 | 52 Week Low | $ | |||
| Day High | $24.11 | P/E | N/A | |||
| Day Low | $23.27 | EPS | $ | |||
| Volume | 1,447,442 | |||||
